<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="369429">
  <stage>Registered</stage>
  <submitdate>1/10/2015</submitdate>
  <approvaldate>27/10/2015</approvaldate>
  <actrnumber>ACTRN12615001139561</actrnumber>
  <trial_identification>
    <studytitle>Randomised control trial of adductor canal block versus intra-articular catheter in knee replacement surgery</studytitle>
    <scientifictitle>In total knee replacement surgery does an adductor canal block or intra-articular catheter with infusions give superior analgesia and range of movement</scientifictitle>
    <utrn>U1111-1175-1388</utrn>
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Knee osteoarthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Adductor canal block versus intra-articular catheter for pain relief in total knee replacement surgery. (Both treatments are given in addition to standard anaesthetic care) 

Group Adductor canal block
Ultrasound guided injection into adductor canal to administer block of femoral nerve at this level of 20ml 0.375% ropivacaine with 8mg dexamethasone. Administered once only immediately prior to surgery. 

</interventions>
    <comparator>Group intra-articular catheter (Both treatments are given in addition to standard anaesthetic care)
10ml 0.75% ropivacaine with 1mcg adrenaline and 30mg ketorolac infused via intra-articular catheter infusion immediately after closure of the wound during surgery and in addition at 24 and 36 hours post operatively. </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary endpoints are 
-a clinically and statistically significant difference in pain as measured by a visual analogue scale 
</outcome>
      <timepoint>daily for the first 3 days
then on discharge day
at 2 week follow up
at 6 weeks
at 3 months
at 6 months post operatively</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>- a clinically and statistically significant difference in range of movement of the operated knee measured by goniometer in degrees. 
</outcome>
      <timepoint>daily for the first 3 days
then on discharge day
at 2 week follow up
at 6 weeks
at 3 months
at 6 months post operatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>- a clinically and statistically significant difference in scores on the Oxford knee score
</outcome>
      <timepoint>pre-operatively and then 
at 2 week follow up
at 6 weeks
at 3 months
and at 6 months post operatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>-Use of breakthrough analgesia as measured by doses of patient controlled analgesia administered / use of PRN analgesia. </outcome>
      <timepoint>daily for the first 3 days
then on discharge day
at 2 week follow up
at 6 weeks
at 3 months
at 6 months post operatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Undergoing Total knee replacement
Able to consent to inclusion in study</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Unable to consent to inclusion in study
Allergy to trial medications </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation will be conducted in a concealed fashion by sealed opaque envelopes. </concealment>
    <sequence>random number generator </sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>7/12/2015</anticipatedstartdate>
    <actualstartdate>20/07/2016</actualstartdate>
    <anticipatedenddate>29/06/2017</anticipatedenddate>
    <actualenddate>1/09/2017</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize>100</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>3/03/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>St John of God Hospital, Murdoch - Murdoch</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>Orthopaedics Western Australia</primarysponsorname>
    <primarysponsoraddress>15/3 Barry Marshall Parade, Murdoch WA 6150</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>Orthopaedics Western Australia</fundingname>
      <fundingaddress>15/3 Barry Marshall Parade, Murdoch WA 6150</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Participation will involve being randomly assigned to one of two routinely used pain management protocols to provide pain relief in the period immediately after total knee replacement surgery. Participants will be unaware as to which group they are in. A pain specialist doctor and nurse will assess pain control and range of movement of the knee at regular intervals following the surgery.  This will assist surgeons and anaesthetists to determine the most effective regimen for future patients.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St John of God Hospital</ethicname>
      <ethicaddress>100 Murdoch Dr, Murdoch WA 6150</ethicaddress>
      <ethicapprovaldate>9/12/2015</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>16/11/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Samuel Duff</name>
      <address>Orthopaedics WA
15/3 Barry Marshall Parade, 
Murdoch WA 6150</address>
      <phone>+61427771900</phone>
      <fax />
      <email>samueljduff@outlook.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Samuel Duff</name>
      <address>Orthopaedics WA
15/3 Barry Marshall Parade, 
Murdoch WA 6150</address>
      <phone>+61427771900</phone>
      <fax />
      <email>samueljduff@outlook.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Samuel Duff</name>
      <address>Orthopaedics WA
15/3 Barry Marshall Parade, 
Murdoch WA 6150</address>
      <phone>+61427771900</phone>
      <fax />
      <email>samueljduff@outlook.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Samuel Duff</name>
      <address>Orthopaedics WA
15/3 Barry Marshall Parade, 
Murdoch WA 6150</address>
      <phone>+61427771900</phone>
      <fax />
      <email>samueljduff@outlook.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>